|
HY-111262-10mg
|
MedChemexpress LLC
|
ABT-384 [CAS 868623-40-9]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-111262-100mg
|
MedChemexpress LLC
|
ABT-384 [CAS 868623-40-9]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-111262-25mg
|
MedChemexpress LLC
|
ABT-384 [CAS 868623-40-9]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-111262-5mg
|
MedChemexpress LLC
|
ABT-384 [CAS 868623-40-9]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-111262-50mg
|
MedChemexpress LLC
|
ABT-384 [CAS 868623-40-9]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-P80544-10uL
|
MedChemexpress LLC
|
Annexin A1 Antibody (YA832)
|
|
|
|
|
HY-P80544-100uL
|
MedChemexpress LLC
|
Annexin A1 Antibody (YA832)
|
|
|
|
|
HY-P80544-50uL
|
MedChemexpress LLC
|
Annexin A1 Antibody (YA832)
|
|
|
|
|
HY-P99439-1mg
|
MedChemexpress LLC
|
Anrukinzumab [CAS 910649-32-0]
|
|
|
|
|
HY-P99439-10mg
|
MedChemexpress LLC
|
Anrukinzumab [CAS 910649-32-0]
|
|
|
|
|
HY-P99439-5mg
|
MedChemexpress LLC
|
Anrukinzumab [CAS 910649-32-0]
|
|
|
|
|
HY-14644A-10mg
|
MedChemexpress LLC
|
Apilimod (mesylate) [CAS 870087-36-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-14644A-100mg
|
MedChemexpress LLC
|
Apilimod (mesylate) [CAS 870087-36-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-14644A-5mg
|
MedChemexpress LLC
|
Apilimod (mesylate) [CAS 870087-36-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-14644A-50mg
|
MedChemexpress LLC
|
Apilimod (mesylate) [CAS 870087-36-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-14644A-1mL
|
MedChemexpress LLC
|
Apilimod (mesylate) [CAS 870087-36-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-14644-10mg
|
MedChemexpress LLC
|
Apilimod [CAS 541550-19-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-14644-100mg
|
MedChemexpress LLC
|
Apilimod [CAS 541550-19-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-14644-5mg
|
MedChemexpress LLC
|
Apilimod [CAS 541550-19-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-14644-50mg
|
MedChemexpress LLC
|
Apilimod [CAS 541550-19-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-14644-1mL
|
MedChemexpress LLC
|
Apilimod [CAS 541550-19-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P80022-10uL
|
MedChemexpress LLC
|
ATG5 Antibody
|
|
|
|
|
HY-P80022-100uL
|
MedChemexpress LLC
|
ATG5 Antibody
|
|
|
|
|
HY-P80022-50uL
|
MedChemexpress LLC
|
ATG5 Antibody
|
|
|
|
|
HY-P80560-10uL
|
MedChemexpress LLC
|
ATP Citrate Lyase Antibody (YA829)
|
|
|
|
